You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

IDO

Showing 1 - 25 of 220
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma, Stage 0a Bladder Cancer AJCC v8, Stage 0is Bladder Cancer AJCC v8

Not yet recruiting
  • High Risk Non-Muscle Invasive Bladder Urothelial Carcinoma
  • +3 more
  • PD-L1/IDO Peptide Vaccine
  • Pembrolizumab
  • Sacramento, California
    University of California Davis Comprehensive Cancer Center
Apr 24, 2023

Metastatic Melanoma Trial in Herlev (Nivolumab, PD-L1/IDO peptide vaccine)

Recruiting
  • Metastatic Melanoma
  • Herlev, Denmark
  • +1 more
Mar 15, 2022

Indoleamine 2,3-dioxygenase Activity in Chronic Lymphocytic

Completed
  • CLL
    • Tampere, Finland
      Tampere university Hospital
    Feb 22, 2022

    NSCLC, Progression of NSCLC, NSCLC Recurrent Trial in Saint Louis, Cincinnati (Docetaxel, Tergenpumatucel-L, Indoximod)

    Terminated
    • Non-small Cell Lung Cancer
    • +2 more
    • Saint Louis, Missouri
    • +1 more
    Apr 4, 2022

    Metastatic Hepatocellular Carcinoma, Stage III Hepatocellular Carcinoma AJCC v8, Stage IIIA Hepatocellular Carcinoma AJCC v8

    Active, not recruiting
    • Metastatic Hepatocellular Carcinoma
    • +7 more
    • IDO1 Inhibitor BMS-986205
    • Nivolumab
    • Sacramento, California
      University of California Davis Comprehensive Cancer Center
    Dec 16, 2021

    Lip, Oral Cavity Squamous Cell Carcinoma, Pharynx Trial in Columbus, Philadelphia (biological, procedure, other)

    Recruiting
    • Lip
    • +4 more
    • Nivolumab
    • +3 more
    • Columbus, Ohio
    • +1 more
    Oct 25, 2021

    Allogeneic Hematopoietic Stem Cell Transplantation Recipient Trial in Columbus (Vitamin A Compound)

    Recruiting
    • Allogeneic Hematopoietic Stem Cell Transplantation Recipient
    • Vitamin A Compound
    • Columbus, Ohio
      Ohio State University Comprehensive Cancer Center
    Mar 24, 2022

    Gastrointestinal Stromal Tumors Trial in Ann Arbor, New York (Pembrolizumab, Epacadostat)

    Completed
    • Gastrointestinal Stromal Tumors
    • Ann Arbor, Michigan
    • +1 more
    Mar 18, 2021

    Endometrial Adenocarcinoma, Endometrial Carcinosarcoma Trial in United States (Nivolumab, BMS- 986205)

    Active, not recruiting
    • Endometrial Adenocarcinoma
    • Endometrial Carcinosarcoma
    • Basking Ridge, New Jersey
    • +6 more
    Nov 29, 2021

    Fallopian Tube Carcinoma, Ovarian Carcinoma, Primary Peritoneal Carcinoma Trial in Buffalo (biological, drug, other)

    Completed
    • Fallopian Tube Carcinoma
    • +2 more
    • DEC-205/NY-ESO-1 Fusion Protein CDX-1401
    • +4 more
    • Buffalo, New York
      Roswell Park Cancer Institute
    Jul 20, 2021

    Advanced Cancer Trial in Worldwide (Relatlimab, Nivolumab, BMS-986205)

    Recruiting
    • Advanced Cancer
    • Relatlimab
    • +3 more
    • Duarte, California
    • +23 more
    Oct 24, 2022

    Glioblastoma Trial in Chicago (biological, radiation, drug)

    Recruiting
    • Glioblastoma
    • IDO1 Inhibitor BMS-986205
    • +3 more
    • Chicago, Illinois
      Northwestern University
    Jun 30, 2020

    Breast Cancer, Lung Cancer, Melanoma Trial in Nashville (1-methyl-D-tryptophan)

    Terminated
    • Breast Cancer
    • +4 more
    • Nashville, Tennessee
      Vanderbilt University
    May 26, 2020

    Solid Tumor Trial in Gainesville, Saint Louis, Albuquerque (NLG802)

    Completed
    • Solid Tumor
    • Gainesville, Florida
    • +2 more
    Jun 3, 2020

    Skin Restricted Lupus, Psychiatric Disorders Trial in Clermont-Ferrand (Biological dosage from plasma)

    Completed
    • Skin Restricted Lupus
    • Psychiatric Disorders
    • Biological dosage from plasma
    • Clermont-Ferrand, France
      CHU Clermont-Ferrand
    Jan 5, 2023

    Melanoma Stage III, Melanoma Stage IV Trial in Boston (Nivolumab, BMS-986205, Ipilimumab)

    Withdrawn
    • Melanoma Stage III
    • Melanoma Stage IV
    • Boston, Massachusetts
    • +1 more
    Feb 3, 2020

    Ependymoma, Medulloblastoma, Glioblastoma Trial in Augusta (Ibrutinib, Indoximod, Cyclophosphamide)

    Recruiting
    • Ependymoma
    • +3 more
    • Augusta, Georgia
      Augusta University, Georgia Cancer Center
    Dec 16, 2022

    Glioblastoma, Glioblastoma Multiforme Trial in Baltimore (Nivolumab, Anti-GITR Monoclonal Antibody MK-4166, IDO1 inhibitor

    Terminated
    • Glioblastoma
    • Glioblastoma Multiforme
    • Baltimore, Maryland
      Johns Hopkins University/Sidney Kimmel Cancer Center
    Jun 30, 2020

    Glioblastoma Multiforme, Glioma, Gliosarcoma Trial in United States (Indoximod, Temozolomide, Conformal Radiation)

    Completed
    • Glioblastoma Multiforme
    • +7 more
    • Aurora, Colorado
    • +4 more
    Jun 3, 2020

    Metastatic Melanoma, Stage III Melanoma, Stage IV Melanoma Trial in United States (Indoximod, Ipilimumab, Nivolumab)

    Completed
    • Metastatic Melanoma
    • +2 more
    • Augusta, Georgia
    • +5 more
    Jun 3, 2020

    Metastatic Pancreatic Adenocarcinoma, Metastatic Pancreatic Cancer Trial in United States (Nab-Paclitaxel, Gemcitabine,

    Completed
    • Metastatic Pancreatic Adenocarcinoma
    • Metastatic Pancreatic Cancer
    • Palo Alto, California
    • +10 more
    May 26, 2020

    Mediastinitis and Staphylococcus Aureus

    Completed
    • Surgery, Cardiac
    • Infection
    • No intervention
    • Rennes, France
      Rennes Hospital University
    Dec 13, 2022

    Stage III Fallopian Tube Cancer AJCC v7, Stage III Ovarian Cancer AJCC v6 and v7, Stage III Primary Peritoneal Cancer AJCC v7

    Active, not recruiting
    • Stage III Fallopian Tube Cancer AJCC v7
    • +14 more
    • Minneapolis, Minnesota
    • +1 more
    Jan 27, 2023

    Glioblastoma, Medulloblastoma, Ependymoma Trial in Augusta, Druid Hills, Boston (Indoximod, Partial Radiation, Full-dose

    Recruiting
    • Glioblastoma
    • +3 more
    • Augusta, Georgia
    • +2 more
    Aug 18, 2022

    Patient Satisfaction Trial in Tel HaShomer (virtual reality headset, colonoscopy with standard sedation.)

    Recruiting
    • Patient Satisfaction
    • virtual reality headset
    • colonoscopy with standard sedation.
    • Tel HaShomer, Israel
      Gastroenterology department, Sheba Medical Center
    Jan 26, 2023